logo-loader
RNS
Samarkand Group PLC

Samarkand Group PLC - Result of General Meeting

RNS Number : 2730H
Samarkand Group PLC
02 May 2025
 

2 May 2025

 

Samarkand Group plc

("Samarkand", the "Company" or together with its subsidiaries the "Group")

Result of General Meeting

 

Samarkand Group plc, (AQSE: SMK), the cross-border eCommerce technology solution provider, announces that all resolutions were duly passed at the Company's General Meeting held on 2 May 2025. The last day of trading in Ordinary Shares on AQSE Growth Market will be 6 May 2025 and the withdrawal will take effect at 7.00 a.m. on 7 May 2025. Trading under the Matched Bargain Facility to be provided by JP Jenkins will commence at 8.00a.m. on 7 May 2025.

 

Details of the voting results, which should be read alongside the Notice of General Meeting, are below:

 

Resolution

Votes for

Votes against

Votes withheld

Total votes


No. of votes

% of votes cast

No. of votes

% of votes cast

No. of votes


SPECIAL RESOLUTION

 

 

 

 

 


1)    Withdrawal of the Company's Ordinary Shares from trading on the AQSE Growth Market

45,798,514

87.55

6,513,106

12.45

0

52,311,620

ORDINARY RESOLUTION







2)    The directors of the Company be authorised to

take all actions reasonable or necessary to effect such withdrawal

22,238,213

77.35

6,513,106

22.65

0

28,751,319

SPECIAL RESOLUTION







3)    The Company be re-registered as a private limited and adopt new articles of association

45,763,314

87.54

6,513,106

12.46

0

52,276,420

 

As at the date of the General Meeting, the issued share capital of the Company comprised 58,358,201 ordinary shares of £0.01 each ("Ordinary Shares") with no shares held in treasury. In accordance with the Company's Articles of Association, on a poll every member has one vote for every share held. Votes withheld are not votes in law. There were no discretionary votes cast. Accordingly, the total number of Ordinary Shares entitling the holders to attend and vote for or against Resolution 1 and 3 was 58,358,201. Pursuant to AQSE Rule 5.3, only Independent Shareholders are eligible to vote on Resolution 2, the total number of Ordinary Shares entitling the holders to attend and vote for or against Resolution 2 was 34,787,900.

 

 

For more information, please contact:

 

Samarkand Group plc

http://samarkand.global/

David Hampstead, Chief Executive Officer

Eva Hang, Chief Financial Officer

info@samarkand.global





Guild Financial Advisory Limited



Ross Andrews

Tomas Klaassen

+44 (0) 7973839767

+44 (0) 7834458095

 



 

Notes to Editors 

 

Samarkand is a consumer brand owner and distributor operating a scale up platform for niche, premium, multichannel, health and healing brands. Core owned brands include Napiers the Herbalists, Scotland's oldest natural herbal apothecary and Zita West, a leading specialist supplement line for fertility and reproductive health. Platform services include marketing, sales and channel development with a focus on social commerce, China market entry, international expansion and manufacturing.  In addition, the group works as the exclusive China market partner for a select portfolio of niche luxury skin care brands and connects these brands to the Chinese consumer via cross border eCommerce.

 

Founded in 2016, Samarkand is headquartered in Tonbridge, UK with offices in Shanghai.

For further information please visit https://www.samarkand.global/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFLFSIEFIFIIE
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

3 min read